Article Details
Retrieved on: 2018-01-02 00:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>02, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata, Inc. announced today that it has acquired Toronto-based <b>Artificial Intelligence</b> in Medicine, Inc. (AIM). AIM has spent more than 30 years developing and commercializing tools that leverage ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here